China 
Africa 
Explore chapters and articles related to this topic
Asthma Epidemiology, Etiology, Pathophysiology and Management in the Current Scenario
Published in Suvardhan Kanchi, Rajasekhar Chokkareddy, Mashallah Rezakazemi, Smart Nanodevices for Point-of-Care Applications, 2022
Manu Sharma, Aishwarya Rathore, Sheelu Sharma, Kakarla Raghava Reddy, Veera Sadhu, Raghavendra V. Kulkarni
The Global Initiative for Asthma (GINA) classified asthma into four major types based on the severity of the disease, i.e. mild intermittent, mild persistent, moderate persistent and severe persistent. Mild intermittent is the least severe whereas severe persistent asthma is the most severe form of asthma (Table 2.1) [3,4]. Despite various advances and modernization in healthcare treatments and facilities, there is still no permanent cure for the disease. Current treatments can provide only symptomatic treatment with a decrease in the progression of the disease. However, there is still a long way to go to improve current treatments, diagnostic tools and patient awareness.
Deep learning-based automated multiclass classification of chest X-rays into Covid-19, normal, bacterial pneumonia and viral pneumonia
Published in Cogent Engineering, 2022
Alok Tiwari, Taresh Sarvesh Sharan, Shiru Sharma, Neeraj Sharma
As of now, there is no particular drug that can cure the disease; instead, we treat it using symptomatic treatment. However, we might not have any symptoms in several cases (Johansson et al., 2021). There are several vaccines (Polack et al., 2020) in the market; none proved to be having 100% efficacy in dealing with coronavirus. Even vaccinated people get affected with Covid-19 (Kissler et al., 2021) but with lesser severity and risk to lives. The main challenges to deal with it – rapid spreading continuously and mutation into several of its variants. Recent coronavirus variants are delta and omicron, which are deadly compared to earlier variants. Researchers have not yet tested vaccine effectiveness on omicron.